Rahul Tuli is a 3rd-year medical student at the University of California, Riverside School of Medicine, and graduated from the University of California, Irvine, with a bachelor’s degree in Human Biology. His interests include vascular surgery and academic research aimed at enhancing clinical outcomes During his Infectious Disease rotation, he became interested in the adjuvant use of Clindamycin in patients with toxin-mediated infections despite its conflicting evidence. As such, Rahul hopes that this research can further uncover insights on the use of unverified medical interventions that may inadvertently contravene the fundamental principle of medicine to “first, not harm.”